Navigation Links
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
Date:12/4/2009

, et al. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report. Am J Psych. 2006; 163: 1905-1917.

(5) El-Khalili N, Joyce M, Atkinson S, et al. Adjunctive extended-release quetiapine fumarate (quetiapine XR) in patients with major depressive disorder and inadequate antidepressant response [poster]. Presented at: The Annual Meeting of the American Psychiatric Association; May 3-8, 2008, Washington, D.C., USA.

(6) Bauer, M, Constant, EL, Szamosi, J. Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients with Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study. J Clin Psych. 2009; e1-e10.

(7) Montgomery SA, Asberg M. A New Depression Scale Designed to be Sensitive to Change. Br J Psychiatry. 1979;134:382-389.

(8) Michaud, CM, McKenna MT, Begg, S, et al. The burden of disease and injury in United States in 1996. Population Health Metrics. 2006; 4:11.

(9) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition Text Revision. Washington DC: 2000.

SOURCE AstraZeneca


'/>"/>
SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
2. FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
4. FDA Approves Agriflu Seasonal Influenza Vaccine
5. FDA Approves Lysteda to Treat Heavy Menstrual Bleeding
6. Rogan-Delft Approves Matrox Xenia Series for Use With Zillion Suite
7. FDA approves GlaxoSmithKlines VOTRIENT(TM) for advanced renal cell cancer
8. FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
9. FDA Approves New Treatment for Advanced Form of Kidney Cancer
10. FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
11. FDA Approves Cervarix, GlaxoSmithKlines Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014  CorMedix Inc. (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... to announce that TUV-SUD and The Medicinal Evaluation ... (MEB) has granted its request for a label ... was initially approved in July 2013 for use ...
(Date:9/22/2014)... and NEW YORK , Sept. ... ACCP), has signed an exclusive, global license agreement ... and commercialization of its proprietary plasma fractionation process. ... team and its intention to strategically refocus and ... its plans to pursue a national listing for ...
(Date:9/22/2014)... cancer is the second leading cause of cancer death ... early - the problem is that too often it ... Education Council (PCEC), – a national organization committed ... screening –  is sponsoring its 25 th Annual ... Committed to encouraging men to take a ...
Breaking Medicine Technology:Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 2PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 3
... 5 Express Scripts (Nasdaq: ESRX ) ... unit to create a new independent, nonprofit charitable organization ... for low-income, uninsured Americans and working families. ... Scripts, leads the new national organization, which has its ...
... Pittsburgh is redistributing its 196 beds to include a third ... broaden its service capabilities and better meet the needs of ... currently operates two locations: the Main Campus at 225 Penn ... Allegheny General Hospital Suburban Campus at 100 South Jackson Avenue. ...
Cached Medicine Technology:Express Scripts Completes Spinoff of Rx Outreach 2LifeCare Hospitals of Pittsburgh Opening Third Location 2
(Date:9/22/2014)... 2014 Join us for a fun-filled evening ... & Pearls Casino Night” Gala. , The event will ... games, a raffle, and live and silent auctions. Beer and ... a special buy-in for a Texas Hold’em tournament and the ... this event will be used to help provide procreation grants ...
(Date:9/22/2014)... 22, 2014 The report covers ... aesthetic lasers and energy devices market revenue and ... Contouring (MIBC) Devices, Non-Invasive Body Contouring (NIBC) Devices ... provides company shares by revenue for the above ...     Information on market size for ...
(Date:9/22/2014)... development is medical imaging which has played an ... and treatments. The devices and machines for medical ... of image processing, pattern recognition, and computer vision ... active research development which are well-covered in this ... partial list of the important contributions reported in ...
(Date:9/22/2014)... 22, 2014--Women who are about to be released from ... planning if they are to successfully reintegrate into their ... new study. , Almost half of all female prisoners ... release and most have multiple prison terms, mainly for ... St. Michael,s Hospital, conducted one-on-one interviews with women who ...
(Date:9/22/2014)... cells take a shortcut for the transmission of information: ... around it like on a bypass road. The previously ... journal " Neuron " by a research team from ... using electrical signals. Via widely ramified cell structuresthe ... transmit them over a thin cell extensionthe axonto other ...
Breaking Medicine News(10 mins):Health News:Maverick’s Miracle Babies Foundation Presents the Denim & Pearls Casino Night September 26, 2014 2Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 2Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 3Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 4Health News:Researchers uncover the frontiers of R&D in medical imaging 2Health News:Involving female offenders in release planning can increase reintegration success 2Health News:Communication without detours 2
... ... ... ... ...
... ... ... ... ...
... , ... ... ... ...
... ... custom stress balls has started 2010 with two record months which points to an economic ... ... balls has started 2010 with two record months which points to an economic upturn ...
... ctp ... this means for leadership and how it is redefining our understanding of soft skills. ... – all leading to better organisations and higher returns on human investment. , ... (PRWEB) March 2, 2010 ...
... Clinically Relevant Technologies ... management guidelines with the release of new medical iPhone app. , ... (PRWEB) March 2, 2010 -- Clinically Relevant Technologies released a new ... care gap. The release comes on the heels of a study published last month in ...
Cached Medicine News:Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 7Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 8Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 9Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 10Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 11Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 12Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 13Health News:MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results 14Health News:Dental Operatory Equipment and Practice Management Software Market in the U.S. to Reach Almost $2 Billion by 2016 2Health News:Dental Operatory Equipment and Practice Management Software Market in the U.S. to Reach Almost $2 Billion by 2016 3Health News:Dental Operatory Equipment and Practice Management Software Market in the U.S. to Reach Almost $2 Billion by 2016 4Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 2Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 3Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 4Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 5Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 6Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 7Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 8Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 9Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 10Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 11Health News:Archimedes Pharma Announces Major Fund Raising of GBP65 Million 12Health News:Promotional Stress Ball Supplier -- StressBallsUK.com Starts 2010 Strongest Ever 2Health News:Key Leadership Seminar: Maximizing Profit through Social Intelligence - What Neuroscience Tells Us 2Health News:Clinically Relevant Technologies Releases New Medical iPhone App To Fill Gap In Adherence To Low Back Pain Management Guidelines 2
For use in implant resection arthroplasty of the trapeziometacarpal joint in cases of rheumatoid, degenerative or post-traumatic arthritis....
The efficient choice for small joint replacement technology -- the Ascension Silicone MCP features a similar design to our PyroCarbon MCP and utilizes the same instrumentation for intra-operative fle...
... SR™ Hand Implant System utilizes the same ... joint replacements. The SR™ Hand Implant ... other prostheses including minimal bone resection, surface ... articular surfaces, retention and/or repositioning of the ...
... the hand can make simple motions such ... key painful, if not impossible. The Avanta ... the disabling effects of this disease. ... and joint-specific design features these implants offer ...
Medicine Products: